Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
Strategies to Secure Access to Generic HCV Medicines
Part 2: How is hepatitis C treated?
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
